-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $30

Benzinga·06/30/2026 14:34:51
Listen to the news
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ:CNXC) with a Outperform and lowers the price target from $38 to $30.